107 related articles for article (PubMed ID: 21370250)
1. Development and validation of a RP-HPLC method for stability-indicating assay of gemifloxacin mesylate including identification of related substances by LC-ESI-MS/MS, 1H and 13C NMR spectroscopy.
Rao RN; Naidu ChG; Prasad KG; Narasimha R
Biomed Chromatogr; 2011 Nov; 25(11):1222-9. PubMed ID: 21370250
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
[TBL] [Abstract][Full Text] [Related]
3. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
Rao RN; Ramakrishna K; Sravan B; Santhakumar K
J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
Rao RN; Raju AN; Narsimha R
J Sep Sci; 2008 Jun; 31(10):1729-38. PubMed ID: 18481321
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Stability-Indicating Assay of Etofenamate by RP-HPLC and Characterization of Degradation Products.
Peraman R; Nayakanti D; Dugga HH; Kodikonda S
Sci Pharm; 2013; 81(4):1017-28. PubMed ID: 24482770
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC.
Nageswara Rao R; Narasa Raju A
J Sep Sci; 2006 Dec; 29(18):2733-44. PubMed ID: 17305234
[TBL] [Abstract][Full Text] [Related]
7. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
8. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
[TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
11. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
12. A Validated Reverse Phase-Ultra-Performance Liquid Chromatography Method for the Determination of Gemifloxacin Mesylate in Bulk and its Pharmaceutical Preparation.
Wagdy HA; Tarek M; Amer A; Gamal M; Elmazar M
Turk J Pharm Sci; 2019 Mar; 16(1):8-13. PubMed ID: 32454688
[TBL] [Abstract][Full Text] [Related]
13. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS.
Rao RN; Farah H; Sahu PK; Janarthan M; Naidu ChG
Biomed Chromatogr; 2013 Dec; 27(12):1733-40. PubMed ID: 23881540
[TBL] [Abstract][Full Text] [Related]
15. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
16. Determination of gemifloxacin in different tissues of rat after oral dosing of gemifloxacin mesylate by LC-MS/MS and its application in drug tissue distribution study.
Roy B; Das A; Bhaumik U; Sarkar AK; Bose A; Mukharjee J; Chakrabarty US; Das AK; Pal TK
J Pharm Biomed Anal; 2010 Jun; 52(2):216-26. PubMed ID: 20092976
[TBL] [Abstract][Full Text] [Related]
17. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
Bansal G; Singh R; Saini B; Bansal Y
J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
[TBL] [Abstract][Full Text] [Related]
18. Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.
Trivedi HK; Patel MC
Sci Pharm; 2012; 80(4):889-902. PubMed ID: 23264938
[TBL] [Abstract][Full Text] [Related]
19. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
[TBL] [Abstract][Full Text] [Related]
20. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
Djabrouhou N; Guermouche MH
J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
